SLC7A11 and fibrosarcoma: To determine whether sorafenib is a bona fide ferroptosis inducer by acting through inhibition of system xc−, we first genetically engineered expression of SLC7A11 in the human fibrosarcoma cell line HT1080 (a widely used cell line in ferroptosis research), as well as the human embryonic kidney cell line HEK293T.